Hudson Bay Capital Management »

Rocket Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.4M 114k 12.57
2024-09-30 $1.2M 65k 18.47

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Eli Lilly & Co. Call Option (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
UnitedHealth Put Option (UNH)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microstrategy Cl A New Call Option (MSTR)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Wellington Management Company
BlackRock
Vanguard Group
Maverick Capital
Westfield Capital Management Company
Citadel Advisors
Henderson Group
State Street Corporation
T. Rowe Price Associates
Suvretta Capital Management
Geode Capital Management
Point72 Asset Management
Frazier Life Sciences Management
Boxer Capital Management

View all funds holding Rocket Pharmaceuticals